Why Juniper Networks Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket

Shares of Juniper Networks, Inc. (NYSE: JNPR) rose sharply in pre-market trading on Tuesday.

Shares of Juniper Networks, Inc. (NYSE:JNPR) rose sharply in pre-market trading on Tuesday.

Hewlett Packard Enterprise Co (NYSE:HPE) is reportedly in advanced discussions to acquire networking equipment competitor Juniper Networks.

Juniper Networks shares climbed 23.3% to $37.26 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Syra Health Corp. (NASDAQ:SYRA) shares rose 56.2% to $1.89 in pre-market trading after jumping 13% on Monday.
  • Notable Labs, Ltd. (NASDAQ:NTBL) shares rose 34.4% to $1.83 in pre-market trading.
  • Galera Therapeutics, Inc. (NASDAQ:GRTX) surged 31.3% to $0.1959 in pre-market trading.
  • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares climbed 13% to $0.5310 in pre-market trading after falling 8% on Monday.
  • Calidi Biotherapeutics, Inc. (NASDAQ:CLDI) shares gained 12.2% to $1.75 in pre-market trading after gaining around 7% on Monday. Calidi Biotherapeutics announced the appointment of three new members to its Scientific and Medical Advisory Board.
  • CN Energy Group. Inc. (NASDAQ:CNEY) shares rose 11.6% to $0.0625 in pre-market trading.
  • Top KingWin Ltd (NASDAQ:TCJH) gained 11.1% to $1.30 in pre-market trading after dipping 39% on Monday.
  • ARB IOT Group Limited (NASDAQ:ARBB) gained 10.4% to $1.69 in pre-market trading.
  • MGO Global, Inc. (NASDAQ:MGOL) gained 8% to $0.6339 in pre-market trading after surging 25% on Monday.

Losers

  • Grifols, S.A. (NASDAQ:GRFS) shares fell 46.3% to $5.98 in pre-market trading.
  • Spectaire Holdings Inc. (NASDAQ:SPEC) shares fell 17.2% to $1.93 in pre-market trading after surging 38% on Monday.
  • Soligenix, Inc. (NASDAQ:SNGX) shares fell 11.3% to $0.8328 in pre-market trading. Soligenix shares gained around 16% on Monday after the company announced that the FDA granted the company’s SGX945 development program for the treatment of Behcet’s Disease a “Fast-Track” designation.
  • Canoo Inc. (NASDAQ:GOEV) shares fell 11.1% to $0.2240 in pre-market trading. Canoo shares gained around 6% on Monday after the company announced the purchase of manufacturing assets “at dramatically reduced prices” to scale production at its Oklahoma City facility.
  • Bit Brother Limited (NASDAQ:BETS) shares fell 10.7% to $0.0058 in pre-market trading after dipping 15% on Monday. Bit Brother announced a 1-for-1,000 reverse share split.
  • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) shares fell 10.4% to $2.86 in pre-market trading after jumping 28% on Monday. The company announced it regained compliance with the Nasdaq minimum bid price requirement.
  • Vincerx Pharma, Inc. (NASDAQ:VINC) fell 8.8% to $1.24 in pre-market trading. Vincerx Pharma shares jumped 14% on Monday after the company released clinical results from a Phase 1 NIH-sponsored study of enitociclib in combination with venetoclax and prednisone for relapsed/refractory lymphoma.
  • Hewlett Packard Enterprise Company (NYSE:HPE) fell 8.5% to $16.21 in pre-market trading. HP might be on the verge of acquiring Juniper Networks, in a deal possibly worth around $13 billion. The announcement could be made as early as this week, according to The Wall Street Journal.
  • Zoomcar Holdings, Inc. (NASDAQ:ZCAR) shares declined 8.1% to $3.65 in pre-market trading after falling around 6% on Monday.
  • QuantaSing Group Limited (NASDAQ:QSG) shares fell 8% to $1.84 in pre-market trading after jumping over 27% on Monday.

 

Now Read This: TD SYNNEX, Albertsons And 3 Stocks To Watch Heading Into Tuesday

Total
0
Shares
Related Posts
Read More

Edgewise Therapeutics Announces Journal Of Clinical Investigation Publication Of Key Preclinical Data Linking Modulation Of Fast Skeletal Muscle Contraction To Protection Of Skeletal Muscle In Models Of Duchenne Muscular Dystrophy

- Data provide key insights supporting Edgewise's strategy to advance EDG-5506 for the treatment of Duchenne and Becker muscular dystrophy - Edgewise Therapeutics, Inc., (NASDAQ:EWTX), a clinical-stage

EWTX